Bladder cancer: Clinical practice guidelines in oncology Journal Article


Authors: Clark, P. E.; Agarwal, N.; Biagioli, M. C.; Eisenberger, M. A.; Greenberg, R. E.; Herr, H. W.; Inman, B. A.; Kuban, D. A.; Kuzel, T. M.; Lele, S. M.; Michalski, J.; Pagliaro, L. C.; Pal, S. K.; Patterson, A.; Plimack, E. R.; Pohar, K. S.; Porter, M. P.; Richie, J. P.; Sexton, W. J.; Shipley, W. U.; Small, E. J.; Spiess, P. E.; Trump, D. L.; Wile, G.; Wilson, T. G.; Dwyer, M.; Ho, M.
Article Title: Bladder cancer: Clinical practice guidelines in oncology
Abstract: Bladder cancer is the fourth most common cancer in the United States. Urothelial carcinoma that originates from the urinary bladder is the most common subtype. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide recommendations on the diagnosis and management of non-muscle-invasive and muscle-invasive urothelial carcinoma of the bladder. This version of the guidelines provides extensive reorganization and updates on the principles of chemotherapy management. Copyright © 2013 by the National Comprehensive Cancer Network. All rights reserved.
Keywords: overall survival; cancer recurrence; cisplatin; doxorubicin; fluorouracil; cancer combination chemotherapy; cancer growth; gemcitabine; paclitaxel; adjuvant therapy; cancer adjuvant therapy; neoadjuvant therapy; methotrexate; cancer staging; nuclear magnetic resonance imaging; follow up; methodology; antineoplastic agent; neoplasm staging; cancer grading; cancer palliative therapy; bcg vaccine; carboplatin; metastasis; progression free survival; quality of life; computer assisted tomography; multiple cycle treatment; antineoplastic combined chemotherapy protocols; pelvis lymphadenectomy; maintenance therapy; practice guideline; pathology; algorithms; bladder cancer; bladder tumor; urinary bladder neoplasms; ifosfamide; vinblastine; docetaxel; urothelium; utilization review; algorithm; conservative treatment; prostate biopsy; cystectomy; nephroureterectomy; carcinoma; neoplasm invasiveness; cystoscopy; external beam radiotherapy; blood cell count; liver function test; transurethral resection; administration, intravesical; mitomycin; bladder carcinoma; muscle neoplasms; transitional cell carcinoma; pemetrexed; muscle tumor; bone scintiscanning; intravesical drug administration; urine cytology; tumor invasion; cancer prognosis; medication compliance; organ sparing treatments
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 11
Issue: 4
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2013-04-01
Start Page: 446
End Page: 475
Language: English
PROVIDER: scopus
PUBMED: 23584347
DOI/URL:
Notes: --- - "Export Date: 1 July 2013" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Harry W Herr
    595 Herr
Related MSK Work